Florida Hospital Ocala INC

Florida Hospital Ocala INC was paid $40.41M by Medicaid between Jan 2018 and Dec 2024, across 266 billing codes. Its largest line is 99283, emergency room visit (moderate) — 20% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	44,681	$611K
2019	162,688	$5.66M
2020	154,523	$5.13M
2021	201,476	$7.51M
2022	240,421	$9.28M
2023	144,345	$7.28M
2024incomplete	88,207	$4.94M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	20%	100,828	93,045	$7.99M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	13%	61,777	55,012	$5.42M
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	9.6%	30,754	9,784	$3.88M
0202U	Oncology (prostate), multianalyte, gene expression profiling	6.0%	10,689	10,403	$2.44M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	5.4%	25,162	21,734	$2.17M
99282	Emergency department visit for the evaluation and management, low to moderate severity	3.8%	19,454	18,200	$1.52M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	3.4%	18,823	6,070	$1.36M
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	3.2%	15,776	15,111	$1.31M
74177	Computed tomography, abdomen and pelvis; with contrast material	3.0%	6,111	5,476	$1.21M
97530	Therapeutic activities, direct patient contact, each 15 minutes	2.0%	15,169	5,343	$821K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	1.9%	11,586	10,086	$785K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	1.6%	22,242	19,317	$630K

254 more codes

96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	1.5%	4,492	$622K
80053	Comprehensive metabolic panel	1.5%	52,757	$588K
96361	Intravenous infusion, hydration; each additional hour	1.4%	11,488	$557K
70450	Computed tomography, head or brain; without contrast material	1.2%	7,555	$493K
96375	Therapeutic injection; each additional sequential IV push	1.2%	15,343	$484K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.2%	5,724	$476K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	6,929	$397K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	4,393	$375K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	9,293	$322K
71275	Computed tomographic angiography, chest, with contrast material	<1%	2,056	$280K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	4,679	$259K
59025	Fetal non-stress test	<1%	3,512	$247K
97161		<1%	2,233	$241K
36415	Collection of venous blood by venipuncture	<1%	9,020	$237K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	4,184	$236K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	2,532	$217K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	6,553	$213K
01999		<1%	2,613	$193K
81003		<1%	15,260	$187K
80048	Basic metabolic panel (calcium, ionized)	<1%	11,479	$182K
72125	Computed tomography, cervical spine; without contrast material	<1%	2,263	$173K
87070		<1%	3,763	$165K
71046	Radiologic examination, chest; 2 views	<1%	8,192	$153K
92523		<1%	1,052	$148K
81025		<1%	11,067	$141K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	2,582	$134K
81001		<1%	32,808	$131K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	1,542	$119K
G0378	Hospital observation service, per hour	<1%	11,300	$113K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	6,352	$103K
87086	Culture, bacterial; quantitative colony count, urine	<1%	9,033	$91K
73610		<1%	1,830	$87K
86901		<1%	3,438	$85K
71045	Radiologic examination, chest; single view	<1%	21,419	$82K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	1,862	$79K
87807		<1%	828	$76K
73630		<1%	2,067	$70K
73130		<1%	1,795	$69K
97165		<1%	615	$68K
82947		<1%	9,143	$67K
P9612	Catheterization for collection of specimen, single patient, all places of service	<1%	829	$62K
97162		<1%	1,518	$61K
12011		<1%	679	$58K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	157	$56K
12001		<1%	790	$54K
73562		<1%	1,907	$50K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	60,567	$47K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	697	$45K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	1,169	$41K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	2,327	$40K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	165	$39K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	25,603	$39K
73110		<1%	1,304	$38K
74018		<1%	2,763	$37K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	3,163	$36K
76819	Fetal biophysical profile; without non-stress testing	<1%	802	$35K
82962		<1%	1,795	$35K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	2,042	$34K
84484		<1%	23,196	$33K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	1,618	$32K
84702		<1%	5,410	$32K
84112		<1%	537	$32K
96376		<1%	4,418	$31K
76801		<1%	3,658	$31K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	2,080	$30K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	246	$30K
73030		<1%	1,381	$27K
93458		<1%	165	$27K
70486		<1%	293	$24K
72131		<1%	579	$24K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	1,233	$24K
84703		<1%	10,285	$23K
73080		<1%	688	$23K
85610		<1%	7,331	$21K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	2,836	$21K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	13,485	$20K
85027		<1%	6,132	$20K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	283	$20K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	362	$18K
J7030	Infusion, normal saline solution , 1000 cc	<1%	16,861	$17K
73090		<1%	502	$17K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	4,048	$16K
72100		<1%	1,361	$16K
82247		<1%	1,483	$16K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	411	$15K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	3,113	$15K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	7,029	$12K
70491		<1%	38	$12K
J8499	Prescription drug, oral, non chemotherapeutic, nos	<1%	1,187	$12K
J2785	Injection, regadenoson, 0.1 mg	<1%	120	$12K
C1769	Guide wire	<1%	1,176	$11K
85730		<1%	5,321	$11K
83735		<1%	6,423	$11K
93971		<1%	1,248	$11K
80076		<1%	253	$11K
87400		<1%	288	$11K
72040		<1%	262	$11K
87210		<1%	1,481	$10K
97113		<1%	49	$9K
80050	General health panel	<1%	895	$9K
12002		<1%	161	$9K
97163		<1%	235	$9K
80061	Lipid panel	<1%	2,754	$9K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	7,741	$8K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	705	$8K
87077		<1%	2,347	$8K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	768	$8K
97166		<1%	103	$8K
71250		<1%	140	$8K
73140		<1%	354	$8K
73590		<1%	366	$7K
J0690	Injection, cefazolin sodium, 500 mg	<1%	1,624	$7K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	3,407	$7K
70498		<1%	17	$7K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	737	$7K
83690		<1%	13,967	$6K
99152		<1%	837	$6K
J7050	Infusion, normal saline solution, 250 cc	<1%	3,584	$5K
J1170	Injection, hydromorphone, up to 4 mg	<1%	3,072	$5K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	10,109	$5K
73502		<1%	383	$5K
83880		<1%	3,189	$5K
97116		<1%	345	$5K
82803		<1%	512	$5K
76506		<1%	57	$5K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	451	$4K
93017		<1%	271	$4K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	213	$4K
93970		<1%	341	$4K
82553		<1%	248	$4K
82550		<1%	912	$4K
86140		<1%	3,698	$4K
J2274	Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg	<1%	314	$4K
84443	Thyroid stimulating hormone (TSH)	<1%	2,450	$4K
99153	Mod sedat endo service >5yrs	<1%	192	$3K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	5,778	$3K
J2704	Injection, propofol, 10 mg	<1%	765	$3K
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	133	$3K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	5,305	$3K
87430		<1%	355	$3K
82248		<1%	943	$3K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	753	$3K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	1,977	$3K
83036	Hemoglobin; glycosylated (A1C)	<1%	1,551	$3K
10060		<1%	116	$2K
87040		<1%	4,253	$2K
85379		<1%	2,789	$2K
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	90	$2K
84295		<1%	501	$2K
99213	Doctor's office visit, returning patient (routine)	<1%	52	$2K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	41	$2K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	24	$2K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	2,477	$2K
76870		<1%	90	$2K
86900		<1%	3,410	$2K
J1644	Injection, heparin sodium, per 1000 units	<1%	1,769	$2K
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	<1%	45	$2K
87186		<1%	2,516	$2K
97150	Therapeutic procedure(s), group (2 or more individuals)	<1%	503	$2K
76775		<1%	135	$2K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	872	$2K
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	<1%	28	$2K
83605		<1%	3,904	$2K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	1,032	$2K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	79	$1K
88304		<1%	210	$1K
86850		<1%	1,596	$1K
74019		<1%	103	$1K
C9113	Injection, pantoprazole sodium, per vial	<1%	801	$1K
29125		<1%	191	$1K
J2060	Injection, lorazepam, 2 mg	<1%	1,537	$1K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	2,028	$1K
84132		<1%	709	$1K
82731		<1%	29	$1K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	1,231	$952.05
88342		<1%	170	$876.19
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	660	$760.55
90714		<1%	321	$706.14
97535	Self-care/home management training, each 15 minutes	<1%	235	$649.36
99218		<1%	104	$607.69
82565		<1%	684	$602.02
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	159	$577.55
J3475	Injection, magnesium sulfate, per 500 mg	<1%	165	$573.89
84156		<1%	248	$569.76
84439		<1%	108	$559.09
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	129	$539.31
93880		<1%	48	$498.85
J3370	Injection, vancomycin hcl, 500 mg	<1%	283	$450.65
85652		<1%	743	$448.75
82077		<1%	1,350	$410.78
86780		<1%	130	$372.49
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	976	$336.09
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	13	$322.01
84145		<1%	500	$310.19
J7121	5% dextrose in lactated ringers infusion, up to 1000 cc	<1%	129	$262.94
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	30	$191.16
93976		<1%	15	$190.31
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	632	$175.73
J0500	Injection, dicyclomine hcl, up to 20 mg	<1%	144	$173.54
G1010	Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program	<1%	152	$162.87
87205		<1%	82	$134.96
84550		<1%	91	$126.30
J2360	Injection, orphenadrine citrate, up to 60 mg	<1%	507	$121.92
82150		<1%	303	$88.88
84520		<1%	481	$80.80
82435		<1%	456	$80.80
82607		<1%	275	$67.03
J0136	Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg	<1%	14	$63.72
76830	Ultrasound, transvaginal	<1%	14	$63.72
J2550	Injection, promethazine hcl, up to 50 mg	<1%	463	$59.73
82746		<1%	129	$58.64
90715		<1%	256	$57.81
96367		<1%	80	$52.36
J1630	Injection, haloperidol, up to 5 mg	<1%	660	$41.05
94760		<1%	357	$40.31
84030		<1%	12	$37.20
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	227	$22.77
J1650	Injection, enoxaparin sodium, 10 mg	<1%	263	$17.03
82330		<1%	505	$13.33
Q3014	Telehealth originating site facility fee	<1%	366	$10.66
82810		<1%	12	$7.35
85014		<1%	356	$4.10
82570		<1%	306	$3.14
85007		0%	91	$0.00
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	0%	222	$0.00
80179		0%	695	$0.00
94664		0%	65	$0.00
J3105	Injection, terbutaline sulfate, up to 1 mg	0%	31	$0.00
80143		0%	113	$0.00
J7510	Prednisolone oral, per 5 mg	0%	697	$0.00
J3486	Injection, ziprasidone mesylate, 10 mg	0%	14	$0.00
J0780	Injection, prochlorperazine, up to 10 mg	0%	61	$0.00
84100		0%	83	$0.00
82009		0%	31	$0.00
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	0%	20	$0.00
83540		0%	14	$0.00
J1953	Injection, levetiracetam, 10 mg	0%	23	$0.00
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	0%	18	$0.00
J1815	Injection, insulin, per 5 units	0%	372	$0.00
J3480	Injection, potassium chloride, per 2 meq	0%	40	$0.00
72128		0%	14	$0.00
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	0%	163	$0.00
96368		0%	16	$0.00
94762		0%	83	$0.00
J0456	Injection, azithromycin, 500 mg	0%	29	$0.00
86308		0%	40	$0.00
70496		0%	15	$0.00
82728		0%	15	$0.00
87081		0%	72	$0.00
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	0%	30	$0.00
J1940	Injection, furosemide, up to 20 mg	0%	59	$0.00
74022		0%	13	$0.00
71101		0%	14	$0.00
J3490	Unclassified drugs	0%	61	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSKULA, ERIKA (CEO)